|

Toripalimab-tpzi Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CHS-007, JS001, LOQTORZI, TAB001

Pipeline

Phase 2: 1

Top Sponsors

  • Massachusetts General Hospital1

Indications

  • Squamous Cell Carcinoma1
  • Head and Neck Cancer Squamous Cell Carcinoma1
  • Head and Neck Cancer1
  • Cancer1

Boston, Massachusetts1 trial

PDT For Induction Therapy For Head And Neck Cancer

Massachusetts General Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.